Blood monocyte-derived CD169(+) macrophages contribute to antitumor immunity against glioblastoma

Infiltrating tumor-associated macrophages (TAM) are known to impede immunotherapy against glioblastoma (GBM), however, TAMs are heterogeneous, and there are no clear markers to distinguish immunosuppressive and potentially immune-activating populations. Here we identify a subset of CD169(+) macropha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyun-Jin, Park, Jang Hyun, Kim, Hyeon Cheol, Kim, Chae Won, Kang, In, Lee, Heung Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585054/
https://www.ncbi.nlm.nih.gov/pubmed/36266311
http://dx.doi.org/10.1038/s41467-022-34001-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585054/
https://www.ncbi.nlm.nih.gov/pubmed/36266311
http://dx.doi.org/10.1038/s41467-022-34001-5

Ejemplares similares